C-Hop Gel 1.125 g

Babies: Information regarding the use of c-hop cream in babies is not available. Lactating mothers: It is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk and is not harmful to the baby. Pregnancy: It is safe to use during pregnancy.
Most studies have shown low or no risk to the developing baby. Driving: No information available. Alcohol: No information available. Liver: No information available. Kidney: No information available..

Vaginal bleeding Headache Abdominal pain Dizziness Depression Breast tenderness Hot flashes Urinary incontinence Vaginal discharge Joint pain.

C-hop cream is an endocrine, metabolic agent. It helps to establish and maintain pregnancy.
It also prevents the increase in thickness of the lining of the uterus caused by oestrogen..

If you miss a dose of progesterone cream, apply the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not apply a double amount to make up for a missed one..

• C-hop cream helps increase your chances of getting pregnant by replacing lower c-hop levels during the luteal phase. It prepares the lining of your uterus to receive and nourish a fertilized egg. • If you become pregnant, c-hop cream can be used for another 10 to 12 weeks until your c-hop levels are high enough. • It also helps regulate the menstrual cycle in women who do not have a regular period due to reducing the hormone c-hop.
• Use each applicator only once to insert the cream into your vagina and then throw it away. • Do not use tampons or other vaginal products for at least 6 hours before and 6 hours after using c-hop cream. • You may get a brownish or white discharge during this time that may cause irritation, pain, or swelling of the vagina.
It is not unusual but inform your doctor if it bothers you..

• C-hop + Anticoagulants: Concurrent use of both drugs may decrease the levels of anticoagulants • C-hop + Antidiabetic agents: Concurrent use of both drugs may decrease the levels of antidiabetic agents • C-hop + Sincalide: Concurrent use of both drugs may decrease the levels of sincalide • C-hop + Ulipristal: Concurrent use of both drugs may decrease the levels of ulipristal • C-hop + Pomalidomide: Concurrent use of both drugs may increase the levels of pomalidomide • C-hop + Antifungal agents: Concurrent use of both drugs may decrease the effects of c-hop • C-hop + Bosentan: Concurrent use of both drugs may decrease the effects of c-hop • C-hop + Efavirenz: Concurrent use of both drugs may result in decreased c-hop exposure • C-hop + Piperaquine: Concurrent use of both drugs may result in increased exposure to cyp2c19 • C-hop + Abametapir: Concurrent use of both drugs may result in increased exposure of cyp3a4.